Cedars-Sinai Investigators to Unveil New Heart Research at AHA 2023
Smidt Heart Institute Experts to Present Study Results on AFib, Sudden Cardiac Arrest
Cardiologists, cardiothoracic surgeons and interventionalists from the Smidt Heart Institute at Cedars-Sinai will unveil research and clinical insights during the American Heart Association (AHA) Scientific Sessions Nov. 11-13 in Philadelphia.
Joanna Chikwe, MD, chair of the Department of Cardiac Surgery and the Irina and George Schaeffer Distinguished Chair in Cardiac Surgery, will lead sessions on valvular heart disease including the Paul Dudley White International Lecture. Chikwe serves as vice chair of the AHA Scientific Sessions.
Sumeet Chugh, MD, director of the Center for Cardiac Arrest Prevention and the Pauline and Harold Price Chair in Cardiac Electrophysiology Research, will moderate an AHA featured science session and share new research on prevention of sudden cardiac death.
Christine Albert, MD, MPH, chair of the Department of Cardiology and the Lee and Harold Kapelovitz Distinguished Chair in Cardiology, will moderate a late-breaking session on shocking decisions in atrial fibrillation (AFib) care. Albert has led pivotal studies that have deepened the medical community’s understanding of the complex disease.
Other Cedars-Sinai experts available for interviews include:
- Susan Cheng, MD, the Erika J. Glazer Chair in Women's Cardiovascular Health and Population Science, who will present on sex differences in heart failure risks and lead a discussion on how aging impacts cardiovascular health.
- Nestor Gonzalez, MD, director of the Neurovascular Laboratory in the Department of Neurosurgery at Cedars-Sinai, who is chair of the Stroke Committee for the annual meeting. He is moderating the Stroke Council Award and Lecture, as well as a session on the latest advances in stroke care.
- Martha Gulati, MD, associate director of the Barbra Streisand Women's Heart Center and director of Preventive Cardiology, who will lead several sessions on women’s heart health and cardiovascular risk.
- David Ouyang, MD, assistant professor of Cardiology at Cedars-Sinai, who will discuss artificial intelligence technology for screening clinical deterioration of heart failure.
- Joseph Ebinger, MD, director of Clinical Analytics in the Department of Cardiology, who will moderate a session on contemporary care and present on how volume influences the effectiveness of electronic tools to improve heart failure care.
To schedule interviews, contact:
Stephanie Cajigal |347-806-2938 | stephanie.cajigal@cshs.org
Cara Martinez | 310-562-7821 | cara.martinez@cshs.org
Follow the meeting live on X using the hashtag #AHA23 and follow Cedars-Sinai on X at @CedarsSinaiMed.